Comparison
NMN vs CoQ10
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
CoQ10
Mitochondrial electron-transport cofactor. Naturally declines with age. Ubiquinol form is the active reduced state.
| Field | NMN | CoQ10 |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 100–300mg |
| Half-life | — | 33h |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEA |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 1700 |
The comparison in plain English
Auto-generated from dataNMN and CoQ10 are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. CoQ10 Mitochondrial electron-transport cofactor.
Bottom line
NMN (evidence B, safety 5/5) has a stronger evidence base than CoQ10 (evidence A, safety 5/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose CoQ10 if
CoQ10 is the better fit when your goal aligns with its mechanism (Cofactor in the mitochondrial electron transport chain at complexes I, II, and III — moves electrons between dehydrogenases and complex III, enabling ATP synthesis) and the dose range (100–300mg) suits your protocol. Half-life is 33h.